AD-O51.4 is a TRAIL-based ligand expressed as a fusion protein with vascular endothelial growth factor VEGF-derived peptides, strongly inhibiting tumor growth and capable of bypassing TRAIL resistance, as well as of inhibiting angiogenesis [28]. Here, VEGFA is linked to neoplasm.